GRM3 and glioblastoma: Moreover, the finding by Ciceroni et al. [55] that the low levels of mGluR3 mRNA expression in tumor specimens correlated with a better survival rate in GBM patients reinforced the idea that the use of an antagonist of mGluR3 might be an important strategy to pursue [54].